The increase of ISG and NKL/Temra in AML+ and TTCR-C4 in AML- (Fig. 5A) was significant (Fig. 5B), with a wide confidence interval for ISG, making the magnitude of this difference unclear. This evidence concerns the gene GLIS2 and acute myeloid leukemia.